Trial Profile
A Double-blind, Randomised, Placebo-controlled, Parallel Group, Dose Escalation Study to Investigate the Safety, Toleration, and Pharmacokinetics of Multiple Oral Doses of IX-01 in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Cligosiban (Primary)
- Indications Premature ejaculation
- Focus Adverse reactions
- Sponsors Ixchelsis
- 09 Nov 2016 Status changed from recruiting to completed.
- 10 Jun 2016 New trial record